0000921530-05-000252.txt : 20120625
0000921530-05-000252.hdr.sgml : 20120625
20050408162928
ACCESSION NUMBER: 0000921530-05-000252
CONFORMED SUBMISSION TYPE: SC 13D/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050408
DATE AS OF CHANGE: 20050408
GROUP MEMBERS: INVESTOR AB
GROUP MEMBERS: INVESTOR GROWTH CAPITAL LIMITED
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ISTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000930553
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 330511719
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13D/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-59537
FILM NUMBER: 05741795
BUSINESS ADDRESS:
STREET 1: 15295 ALTON PARKWAY
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-788-6000
MAIL ADDRESS:
STREET 1: 15295 ALTON PARKWAY
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: ADVANCED CORNEAL SYSTEMS INC
DATE OF NAME CHANGE: 20000403
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: INVESTOR AB
CENTRAL INDEX KEY: 0000889232
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: SC 13D/A
BUSINESS ADDRESS:
STREET 1: ARAENALSGATAN SC
STREET 2: S-103 32
CITY: STOCKHOLM SWEDEN
STATE: V7
ZIP: 00000
BUSINESS PHONE: 2125159000
MAIL ADDRESS:
STREET 1: KIRKPATRICK & LOCKHART LLP
STREET 2: 1500 OLIVER BUILDING
CITY: PITTSBURGH
STATE: PA
ZIP: 15222
SC 13D/A
1
ista_13da2-040805.txt
AMENDMENT 04/08/05
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
ISTA PHARMACEUTICALS, INC.
--------------------------
(Name of Issuer)
Common Stock, Par Value $.001 Per Share
---------------------------------------
(Title of Class of Securities)
45031X105
----------------
(CUSIP Number)
James E. Kaye, Esq.
Akin Gump Strauss Hauer & Feld LLP
590 Madison Avenue
New York, New York 10022
(212) 872-1000
-------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
April 8, 2005
--------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box [ ].
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule ss.240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Continued on following page(s)
Page 1 of 14 Pages
SCHEDULE 13D
CUSIP No. 45031X105 Page 2 of 14 Pages
1 Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities only)
INVESTOR GROWTH CAPITAL LIMITED
2 Check the Appropriate Box If a Member of a Group (See Instructions)
a. [ ]
b. [X]
3 SEC Use Only
4 Source of Funds (See Instructions)
Not Applicable
5 Check Box If Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Guernsey
Number of 7 Sole Voting Power
Shares 2,001,896
Beneficially
Owned By 8 Shared Voting Power
Each 0
Reporting
Person 9 Sole Dispositive Power
With 2,001,896
10 Shared Dispositive Power
0
11 Aggregate Amount Beneficially Owned by Each Reporting Person
2,001,896
12 Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
[X]
13 Percent of Class Represented By Amount in Row (11)
7.78%
14 Type of Reporting Person (See Instructions)
OO
SCHEDULE 13D
CUSIP No. 45031X105 Page 3 of 14 Pages
1 Names of Reporting Persons
I.R.S. Identification Nos. of above persons (entities only)
INVESTOR AB
2 Check the Appropriate Box If a Member of a Group (See Instructions)
a. [ ]
b. [X]
3 SEC Use Only
4 Source of Funds (See Instructions)
Not Applicable
5 Check Box If Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e) [ ]
6 Citizenship or Place of Organization
Sweden
Number of 7 Sole Voting Power
Shares 2,859,850
Beneficially
Owned By 8 Shared Voting Power
Each 0
Reporting
Person 9 Sole Dispositive Power
With 2,859,850
10 Shared Dispositive Power
0
11 Aggregate Amount Beneficially Owned by Each Reporting Person
2,859,850
12 Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions)
[ ]
13 Percent of Class Represented By Amount in Row (11)
11.11%
14 Type of Reporting Person (See Instructions)
OO
Page 4 of 14 Pages
This Amendment No. 2 to Schedule 13D relates to shares of
common stock, par value $.001 per share (the "Shares"), of ISTA Pharmaceuticals,
Inc. (the "Issuer"). This Amendment No. 2 supplementally amends the initial
statement on Schedule 13D, dated September 30, 2002, and Amendment No. 1 on
Schedule 13D, dated November 19, 2002 (together, the "Initial Statement"). This
Amendment No. 2 is being filed by the Reporting Persons (as defined below) to
report that the number of Shares of which each of the Reporting Persons may be
deemed to be the beneficial owner has decreased by more than one percent of the
amount of Shares outstanding. Capitalized terms used but not defined herein
shall have the meanings ascribed to them in the Initial Statement. The Initial
Statement is supplementally amended as follows.
Item 2. Identity and Background.
This statement is being filed on behalf of each of the
following persons (together, the "Reporting Persons"):
i) Investor Growth Capital Limited ("Investor Growth
Capital"); and
ii) Investor AB ("Investor AB").
This Statement relates to securities held by each of Investor
Growth Capital and a limited partnership of which Investor AB serves as the
ultimate general partner (the "Fund").
Investor Growth Capital is a Guernsey company, with its
principal place of business at National Westminster House, Le Truchot, St. Peter
Port, Guernsey, Channel Islands GYI, 4PW. Investor Growth Capital is a wholly
owned subsidiary of a Dutch company, which is a wholly owned subsidiary of a
Swedish company, which is a wholly owned subsidiary of Investor AB. The
principal business of Investor Growth Capital is investments in securities.
Updated information concerning the identity and background of the directors and
officers of Investor Growth Capital is set forth in Annex A hereto, which is
incorporated by reference in response to this Item 2.
Investor AB, is a publicly held Swedish company, with its
principal place of business at Arsenalsgatan 8c, S-103 32 Stockholm, Sweden. Its
principal business is as a diversified industrial holdings company. Updated
information concerning the identity and background of the directors and officers
of Investor AB is set forth in Annex A hereto, which is incorporated by
reference in response to this Item 2.
During the past five years, none of the Reporting Persons and,
to the best of the Reporting Persons' knowledge, no other person identified in
response to this Item 2 has been (a) convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors) or (b) a party to any
civil proceeding of a judicial or administrative body of competent jurisdiction
and as a result of such proceeding was or is subject to a judgment, decree or
final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any violation
with respect to such laws.
Item 5. Interest in Securities of the Issuer.
The percentages set forth below are calculated on the basis of
the Issuer having 25,747,492 Shares outstanding as of March 8, 2005, as stated
in the Issuer's most recent annual report on Form 10-K.
Page 5 of 14 Pages
(a) (i) Investor Growth Capital may be deemed the beneficial
owner of 2,001,896 Shares held for its account (approximately 7.78% of the total
number of Shares outstanding).
(ii) Investor AB may be deemed the beneficial owner of
2,859,850 Shares (approximately 11.11% of the total number of Shares
outstanding). This number consists of A) 2,001,896 Shares held for the account
of Investor Growth Capital and B) 857,954 Shares held for the account of the
Fund.
(b) (i) Investor Growth Capital may be deemed to have sole
power to direct the voting and disposition of the 2,001,896 Shares held for its
account.
(ii) Investor AB may be deemed to have sole power to
direct the voting and disposition of 2,859,850 Shares held for the accounts of
Investor Growth Capital and the Fund. This number consists of A) 2,001,896
Shares held for the account of Investor Growth Capital and B) 857,954 Shares
held for the account of the Fund.
(c) Except for the transactions listed on Annex B hereto,
there have been no transactions effected with respect to the Shares since
February 7, 2005 (60 days prior to the date hereof) by any of the Reporting
Persons.
(d) (i) The shareholders of Investor Growth Capital, including
Investor AB, have the right to participate in the receipt of dividends from, or
the proceeds from the sale of, the securities held for the account of Investor
Growth Capital in accordance with their ownership interests in Investor Growth
Capital.
(ii) The partners of the Fund, including Investor AB, have
the right to participate in the receipt of dividends from, or the proceeds from
the sale of, the securities held for the account of the Fund in accordance with
their ownership interests in the Fund.
(e) Not applicable.
Page 6 of 14 Pages
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, each
of the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Date: April 8, 2005 INVESTOR GROWTH CAPITAL LIMITED
By: /s/ Michael Oporto
------------------------------------
Michael Oporto
Attorney-in-Fact
By: /s/ Henry Gooss
------------------------------------
Henry Gooss
Attorney-in-Fact
Date: April 8, 2005 INVESTOR AB
By: /s/ Michael Oporto
------------------------------------
Michael Oporto
Attorney-in-Fact
By: /s/ Henry Gooss
------------------------------------
Henry Gooss
Attorney-in-Fact
Page 7 of 14 Pages
ANNEX A
Directors and Officers of Investor Growth Capital Limited
Name/Title/Citizenship Principal Occupation Business Address
---------------------- -------------------- -----------------
Lisa Crawford Managing Director of National Westminster House
A-Director Abacus Financial Services Le Truchot, St. Peter Port
(British) (Guernsey) Limited Guernsey, GY1 4 PW
Mary Lacey Managing Director of National Westminster House
A-Director Abacus Financial Services Le Truchot, St. Peter Port
(British) (Guernsey) Limited Guernsey, GY1 4 PW
Neil J. Crocker Managing Director of National Westminster House
A-Director Abacus Financial Services Le Truchot, St. Peter Port
(British) (Guernsey) Limited Guernsey, GY1 4 PW
Wayne Tallowin Managing Director of National Westminster House
A-Director Abacus Financial Services Le Truchot, St. Peter Port
(British) (Guernsey) Limited Guernsey, GY1 4 PW
Marc Hollander Managing Director of World Trade Center
B-Director Investor Growth Capital Tower D, 11th Floor
(Dutch) Holding B.V. Strawinskylaan 1159
107XX Amsterdam
The Netherlands
Robert de Heus Investment Controller of World Trade Center
B-Director Investor Growth Capital Tower D, 11th Floor
(Dutch) Holding B.V. Strawinskylaan 1159
107XX Amsterdam
The Netherlands
Anders Berg Vice President of Arsenalsgatan 8c
B-Director Investor AB S-103 32 Stockholm
(Swedish) Sweden
To the best of the Reporting Persons' knowledge:
(a) None of the above persons hold any Shares.
(b) None of the above persons has any contracts,
arrangements, understandings or relationships with respect to the Shares.
Page 8 of 14 Pages
Directors and Executive Officers of Investor AB
The name, business address, title, present principal occupation or
employment of each of the directors and executive officers of Investor AB are
set forth below. If no business address is given, the director's or officer's
business address is Arsenalsgatan 8C, S-103 32 Stockholm, Sweden. Unless
otherwise indicated, each occupation set forth opposite an individual's name
refers to Investor AB. Unless otherwise indicated below, all of the persons
listed below are citizens of Sweden.
Present Principal Occupation Including
Name and Business Address Name and Address of Employer
------------------------- --------------------------------------
Directors
Claes Dahlback Chairman.
Chairman of EQT, Gambro AB, Stora Enso Oyj and V & S Group
AB, Investor Capital Partners. Vice Chairman of W Capital
Management AB, Director of Goldman Sachs & Co.
Anders Scharp Member of the board.
Chairman of Saab AB, AB SKF and AB Ph. Nederman & Co.
Hakan Mogren Member of the board.
Chairman of Affibody AB.
Vice Chairman of Gambro AB, Deputy Chairman of AstraZeneca
PLC. Director of Group Danone, Norsk Hydro ASA, Remy
Cointreau SA, The Marianne and Marcus Wallenberg
Foundation. Chairman of the Swedish-American Foundation.
Member of the Royal Swedish Academy of Engineering Sciences
(IVA) and the Swedish Gastronomic Acadamy.
Sune Carlsson Member of the board.
Chairman of Atlas Copco AB. Director of Autoliv Inc.,
Picanol NV and Scania AB.
Peter D. Sutherland Member of the board.
(Citizen of Ireland) Chairman of BP plc and Goldman Sachs International.
Director of the Royal Bank of Scotland Group Plc., The
Royal Bank of Scotland plc, and the National Westminster
Bank Plc.
Bjorn Svedberg Member of the board.
Chairman of Hi3G Access AB and Nefab AB. Director of Saab
AB and the Knut and Alice Wallenberg Foundation.
Member of the Royal Swedish Academy of Engineering Sciences
(IVA) and the Morgan Stanley European Advisory Board.
Page 9 of 14 Pages
Present Principal Occupation Including
Name and Business Address Name and Address of Employer
------------------------- --------------------------------------
Marcus Wallenberg President and Chief Executive Officer.
Vice Chairman of Telefonaktiebolaget L M Ericsson, Saab AB
and SEB Skandinaviska Banken AB. Director of Astra Zeneca
AB, Hi3G Access AB, Scania AB, Stora Enso Oyj, EQT Partners
and the Knut and Alice Wallenberg Foundation.
Jacob Wallenberg Vice Chairman.
Chairman of SEB Skandinaviska Enskilda Banken and W Capital
Management AB. Vice Chairman of Atlas Copco AB, the Knut
and Alice Wallenberg Foundation and SAS AB. Director of ABB
Ltd., the Confederation of Swedish Enterprise and the Nobel
Foundation.
Sirkka Hamalainen Member of the Board.
(Citizen of Finland) Director of Kone Corporation, Helsinki School of Economics
Holding Oy and SanomaWSOY.
Ulla Litzen Member of the Board.
President of W Capital Management AB, Director of AB Svensk
Stiftelseforvaltning, Atlas Copco AB, Karo Bio AB, AB SKF
and Posten AB.
O. Griffith Sexton Member of the Board.
(Citizen of the Advisory Director at Morgan Stanley; Adjunct Professor at
United States) Columbia Business School and visiting lecturer at Princeton
University's Bendheim Center for Finance.
Peter Wallenberg Honorary Chairman.
Chairman of the Knut and Alice Wallenberg Foundation and
Honorary Chairman of Atlas Copco AB.
Present Principal Occupation Including
Name and Business Address Name and Address of Employer
----------------------------------------- --------------------------------------
Executive Officers(Who Are Not Directors)
Borje Ekholm Executive Vice President
Lars Wedenborn Executive Vice President
Henry E. Gooss Managing Director
Adine Grate Axen Managing Director
Fredrik Hillelson Managing Director
To the best of the Reporting Persons' knowledge:
(a) None of the above persons hold any Shares.
(b) None of the above persons has any contracts, arrangements,
understandings or relationships with respect to the Shares.
Page 10 of 14 Pages
ANNEX B
RECENT TRANSACTIONS IN THE SECURITIES OF
ISTA PHARMACEUTICALS, INC.
Approximate
Date of Nature of Number of Price per
For the Account of Transaction Transaction Shares Share
------------------ ----------- ----------- --------- ----------
Investor Growth Capital Ltd. 2/17/2005 Open Market 3,500 $10.50
Sale
Investor Growth Capital Ltd. 2/17/2005 Open Market 70 $10.56
Sale
Investor Growth Capital Ltd. 2/17/2005 Open Market 70 $10.57
Sale
Investor Growth Capital Ltd. 2/17/2005 Open Market 452 $10.60
Sale
Investor Growth Capital Ltd. 2/17/2005 Open Market 70 $10.63
Sale
Investor Group LP 2/17/2005 Open Market 1,500 $10.50
Sale
Investor Group LP 2/17/2005 Open Market 30 $10.56
Sale
Investor Group LP 2/17/2005 Open Market 30 $10.57
Sale
Investor Group LP 2/17/2005 Open Market 193 $10.60
Sale
Investor Group LP 2/17/2005 Open Market 30 $10.63
Sale
Investor Growth Capital Ltd. 2/23/2005 Open Market 6,090 $10.00
Sale
Investor Growth Capital Ltd. 2/23/2005 Open Market 210 $10.02
Sale
Investor Growth Capital Ltd. 2/23/2005 Open Market 70 $10.01
Sale
Investor Growth Capital Ltd. 2/23/2005 Open Market 280 $10.03
Sale
Investor Growth Capital Ltd. 2/23/2005 Open Market 4,240 $10.05
Sale
Investor Growth Capital Ltd. 2/23/2005 Open Market 769 $10.06
Sale
Investor Growth Capital Ltd. 2/23/2005 Open Market 70 $10.07
Sale
Investor Growth Capital Ltd. 2/23/2005 Open Market 1,400 $10.10
Sale
Investor Growth Capital Ltd. 2/23/2005 Open Market 210 $10.15
Sale
Investor Group LP 2/23/2005 Open Market 2,610 $10.00
Sale
Page 11 of 14 Pages
Approximate
Date of Nature of Number of Price per
For the Account of Transaction Transaction Shares Share
------------------ ----------- ----------- --------- ----------
Investor Group LP 2/23/2005 Open Market 90 $10.02
Sale
Investor Group LP 2/23/2005 Open Market 30 $10.01
Sale
Investor Group LP 2/23/2005 Open Market 120 $10.03
Sale
Investor Group LP 2/23/2005 Open Market 1,816 $10.05
Sale
Investor Group LP 2/23/2005 Open Market 330 $10.06
Sale
Investor Group LP 2/23/2005 Open Market 30 $10.07
Sale
Investor Group LP 2/23/2005 Open Market 600 $10.10
Sale
Investor Group LP 2/23/2005 Open Market 90 $10.15
Sale
Investor Growth Capital Ltd. 2/24/2005 Open Market 10,780 $9.95
Sale
Investor Growth Capital Ltd. 2/24/2005 Open Market 140 $9.93
Sale
Investor Growth Capital Ltd. 2/24/2005 Open Market 70 $9.94
Sale
Investor Growth Capital Ltd. 2/24/2005 Open Market 3,010 $9.90
Sale
Investor Group LP 2/24/2005 Open Market 4,620 $9.95
Sale
Investor Group LP 2/24/2005 Open Market 60 $9.93
Sale
Investor Group LP 2/24/2005 Open Market 30 $9.94
Sale
Investor Group LP 2/24/2005 Open Market 1,290 $9.90
Sale
Investor Growth Capital Ltd. 2/25/2005 Open Market 420 $10.34
Sale
Investor Growth Capital Ltd. 2/25/2005 Open Market 2,660 $10.40
Sale
Investor Growth Capital Ltd. 2/25/2005 Open Market 70 $10.41
Sale
Investor Growth Capital Ltd. 2/25/2005 Open Market 350 $10.44
Sale
Investor Group LP 2/25/2005 Open Market 180 $10.34
Sale
Investor Group LP 2/25/2005 Open Market 1,140 $10.40
Sale
Page 12 of 14 Pages
Approximate
Date of Nature of Number of Price per
For the Account of Transaction Transaction Shares Share
------------------ ----------- ----------- --------- ----------
Investor Group LP 2/25/2005 Open Market 30 $10.41
Sale
Investor Group LP 2/25/2005 Open Market 150 $10.44
Sale
Investor Growth Capital Ltd. 3/16/2005 Open Market 3,500 $9.04
Sale
Investor Growth Capital Ltd. 3/16/2005 Open Market 3,500 $9.06
Sale
Investor Growth Capital Ltd. 3/16/2005 Open Market 280 $9.07
Sale
Investor Growth Capital Ltd. 3/16/2005 Open Market 70 $9.08
Sale
Investor Growth Capital Ltd. 3/16/2005 Open Market 2,940 $9.10
Sale
Investor Growth Capital Ltd. 3/16/2005 Open Market 210 $9.14
Sale
Investor Group LP 3/16/2005 Open Market 1,500 $9.04
Sale
Investor Group LP 3/16/2005 Open Market 1,500 $9.06
Sale
Investor Group LP 3/16/2005 Open Market Sale 120 $9.07
Investor Group LP 3/16/2005 Open Market 30 $9.08
Sale
Investor Group LP 3/16/2005 Open Market 1,260 $9.10
Sale
Investor Group LP 3/16/2005 Open Market 90 $9.14
Sale
Investor Growth Capital Ltd. 3/17/2005 Open Market 2,555 $8.90
Sale
Investor Growth Capital Ltd. 3/17/2005 Open Market 1,435 $8.91
Sale
Investor Growth Capital Ltd. 3/17/2005 Open Market 1,540 $8.92
Sale
Investor Growth Capital Ltd. 3/17/2005 Open Market 1,470 $8.93
Sale
Investor Group LP 3/17/2005 Open Market 1,095 $8.90
Sale
Investor Group LP 3/17/2005 Open Market 615 $8.91
Sale
Investor Group LP 3/17/2005 Open Market 660 $8.92
Sale
Investor Group LP 3/17/2005 Open Market 630 $8.93
Sale
Page 13 of 14 Pages
Approximate
Date of Nature of Number of Price per
For the Account of Transaction Transaction Shares Share
------------------ ----------- ----------- --------- ----------
Investor Growth Capital Ltd. 3/21/2005 Open Market 1,470 $9.60
Sale
Investor Growth Capital Ltd. 3/21/2005 Open Market 770 $9.63
Sale
Investor Growth Capital Ltd. 3/21/2005 Open Market 280 $9.65
Sale
Investor Growth Capital Ltd. 3/21/2005 Open Market 1,470 $9.66
Sale
Investor Growth Capital Ltd. 3/21/2005 Open Market 1,050 $9.68
Sale
Investor Growth Capital Ltd. 3/21/2005 Open Market 630 $9.70
Sale
Investor Growth Capital Ltd. 3/21/2005 Open Market 70 $9.67
Sale
Investor Growth Capital Ltd. 3/21/2005 Open Market 2,940 $9.55
Sale
Investor Growth Capital Ltd. 3/21/2005 Open Market 70 $9.56
Sale
Investor Growth Capital Ltd. 3/21/2005 Open Market 1,750 $9.57
Sale
Investor Group LP 3/21/2005 Open Market 630 $9.60
Sale
Investor Group LP 3/21/2005 Open Market 330 $9.63
Sale
Investor Group LP 3/21/2005 Open Market 120 $9.65
Sale
Investor Group LP 3/21/2005 Open Market 630 $9.66
Sale
Investor Group LP 3/21/2005 Open Market 450 $9.68
Sale
Investor Group LP 3/21/2005 Open Market 270 $9.70
Sale
Investor Group LP 3/21/2005 Open Market 30 $9.67
Sale
Investor Group LP 3/21/2005 Open Market 1,260 $9.55
Sale
Investor Group LP 3/21/2005 Open Market 30 $9.56
Sale
Investor Group LP 3/21/2005 Open Market 750 $9.57
Sale
Investor Growth Capital Ltd. 3/23/2005 Open Market 70 $9.85
Sale
Investor Growth Capital Ltd. 3/23/2005 Open Market 140 $9.83
Sale
Page 14 of 14 Pages
Approximate
Date of Nature of Number of Price per
For the Account of Transaction Transaction Shares Share
------------------ ----------- ----------- --------- ----------
Investor Growth Capital Ltd. 3/23/2005 Open Market 4,200 $9.80
Sale
Investor Group LP 3/23/2005 Open Market 30 $9.85
Sale
Investor Group LP 3/23/2005 Open Market 60 $9.83
Sale
Investor Group LP 3/23/2005 Open Market 1,800 $9.80
Sale
Investor Growth Capital Ltd. 3/28/2005 Open Market 6,090 $10.25
Sale
Investor Growth Capital Ltd. 3/28/2005 Open Market 7,000 $10.50
Sale
Investor Group LP 3/28/2005 Open Market 2,610 $10.25
Sale
Investor Group LP 3/28/2005 Open Market 3,000 $10.50
Sale